BioNTech Manufacturing GmbH
BiotechBioNTech Manufacturing GmbH is a biotechnology company with 1 FDA-approved products.
BioNTech Manufacturing GmbH's Key Drugs
BioNTech Manufacturing GmbH's core commercial portfolio centers on Comirnaty — its most strategically important drugs approved in the last 15 years.
BioNTech Manufacturing GmbH's Recent FDA Approvals
New NDA/BLA approvals for BioNTech Manufacturing GmbH over the last two years — novel drugs only, excluding generics and label supplements.
BioNTech Manufacturing GmbH's Therapeutic Areas
Disease areas where BioNTech Manufacturing GmbH has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
BioNTech Manufacturing GmbH Pipeline Snapshot
Active clinical trials for BioNTech Manufacturing GmbH across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Comirnaty leads revenue
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2021-08-22
- Latest
- 2021-08-22
- Applications
- 1